FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3771416 · Received April 24, 2014

Report

Report Number
2124215-2014-09213
Event Type
Malfunction
Date Received
April 24, 2014
Date of Event
February 19, 2012
Report Date
February 20, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE RIGHT VENTRICULAR (RV) LEAD WAS EXHIBITING HIGH PACING IMPEDANCE MEASUREMENTS GREATER THAN 2,000 OHMS. THERE WAS NO EVIDENCE OF NOISE ON THE RV LEAD. THE PRESENTING ELECTROGRAM (EGM) INDICATED INTRINSIC ATRIAL SENSING WITH VENTRICULAR PACING MARKERS. THE MORPHOLOGY ON THE SHOCK CHANNEL INDICATED APPROPRIATE CAPTURE. NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS CLINICAL OBSERVATION. THE DEVICE REMAINS IMPLANTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
248537 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 70 YR E110| 4470| 0175